Test Code LAB1231780 Porphyrins, Total, Plasma
Performing Laboratory
Mayo Clinic Laboratories in Rochester
Reporting Name
Porphyrins, Total, PSpecimen Type
PlasmaShipping Instructions
Ship specimen in amber vial to protect from light.
Necessary Information
Include a list of medications the patient is currently taking.
Specimen Required
Patient Preparation: For 24 hours before specimen collection, patient must not consume any alcohol.
Supplies: Amber Frosted Tube, 5 mL (T915)
Collection Container/Tube:
Preferred: Green top (sodium or lithium heparin)
Acceptable: Lavender top (EDTA)
Submission Container/Tube: Amber vial
Specimen Volume: 3 mL Plasma
Collection Instructions: Centrifuge specimen and aliquot plasma into an amber vial.
Reject Due To
| Gross hemolysis | OK |
| Gross lipemia | OK |
| Gross icterus | OK |
Specimen Stability Information
| Specimen Type | Temperature | Time | Special Container |
|---|---|---|---|
| Plasma | Frozen (preferred) | 14 days | LIGHT PROTECTED |
| Refrigerated | 14 days | LIGHT PROTECTED |
Specimen Minimum Volume
Plasma: 1 mL
Special Instructions
Day(s) Performed
Monday through Friday
Specimen Retention Time
14 daysReport Available
2 to 4 daysReference Values
≤1.0 mcg/dL
Reflex Tests
| Test ID | Reporting Name | Available Separately | Always Performed |
|---|---|---|---|
| PFP | Porphyrins, Fractionation, P | No | No |
Useful For
Monitoring treatment of patients with porphyria cutanea tarda
Testing Algorithm
If total porphyrins are above 1.0 mcg/dL, then porphyrin fractionation will be performed at an additional charge.
The following algorithms are available:
CPT Code Information
84311-Porphyrins, total
82542-Porphyrins, fractionation (if appropriate)
LOINC Code Information
| Test ID | Test Order Name | Order LOINC Value |
|---|---|---|
| PTP | Porphyrins, Total, P | 2815-9 |
| Result ID | Test Result Name | Result LOINC Value |
|---|---|---|
| 8731 | Porphyrins, Total, P | 2815-9 |
| 34252 | Reviewed By | 18771-6 |
| 33869 | Interpretation | 59462-2 |
Method Description
The plasma porphyrins profile is performed as a 2-step analysis. First, the total plasma porphyrins concentration is determined by extracting the porphyrins from plasma with a mixture of ethyl acetate and acetic acid. The porphyrins are then back extracted into dilute hydrochloric acid. Total porphyrins are quantified on this extract via scanning spectrofluorometry. If the total plasma porphyrin concentration is elevated, the extract is submitted for high-performance liquid chromatography analysis, whereby the individual porphyrin analytes are separated by differential partitioning between a stationary aliphatic surface and a moving aqueous buffer solution. As the porphyrins emerge separately from the column, the quantity of each is monitored with a fluorescence detector.(Unpublished Mayo method)
Genetics Test Information
Plasma specimens from patients with active porphyria cutanea tarda, congenital erythropoietic porphyria, and erythropoietic protoporphyria may exhibit increased plasma porphyrin levels. However, a definitive diagnosis cannot be made by plasma analysis alone.
Forms
If not ordering electronically, complete, print, and send a Biochemical Genetics Test Request (T798) with the specimen.